|
EIF2B2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.342500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.589700E-02 |
| Normal-vs-Stage2 |
6.590200E-02 |
| Normal-vs-Stage3 |
9.175000E-01 |
| Normal-vs-Stage4 |
6.664600E-01 |
| Stage1-vs-Stage2 |
5.767400E-01 |
| Stage1-vs-Stage3 |
2.135400E-01 |
| Stage1-vs-Stage4 |
7.269200E-01 |
| Stage2-vs-Stage3 |
2.197200E-01 |
| Stage2-vs-Stage4 |
5.436000E-01 |
| Stage3-vs-Stage4 |
7.311000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.081800E-02 |
| Normal-vs-AfricanAmerican |
7.003600E-02 |
| Normal-vs-Asian |
9.030800E-01 |
| Caucasian-vs-AfricanAmerican |
8.985200E-01 |
| Caucasian-vs-Asian |
6.606200E-01 |
| AfricanAmerican-vs-Asian |
6.465400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.386100E-02 |
| Normal-vs-Female |
2.621200E-01 |
| Male-vs-Female |
5.438600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.278000E-01 |
| Normal-vs-Extreme_Weight |
3.830400E-02 |
| Normal-vs-Obese |
4.479400E-01 |
| Normal-vs-Extreme_Obese |
3.271700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.910400E-01 |
| Normal_Weight-vs-Obese |
6.201600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.194230E-01 |
| Extreme_Weight-vs-Obese |
2.894600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.107960E-01 |
| Obese-vs-Extreme_Obese |
5.577600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.611200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.861200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.219500E-03 |
| Normal-vs-Age(81-100Yrs) |
6.407500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.547400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.439200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.863400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.635600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.726800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.806800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.634170E-01 |
| Normal-VS-Type2 PRCC |
2.261200E-01 |
| Normal-VS-KIRP CIMP |
3.369000E-01 |
| Normal-VS-Unclassified PRCC |
7.928300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.346000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.006000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.498000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.381800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.540000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.980400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.361770E-02 |
| Normal-vs-N1 |
7.371200E-01 |
| Normal-vs-N2 |
4.421800E-02 |
| N0-vs-N1 |
2.178000E-01 |
| N0-vs-N2 |
6.593800E-01 |
| N1-vs-N2 |
4.114600E-01 |
|
|
